← Open Payments lookup

DIANE GLENDINNING: Open Payments

NPI 1710253612 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$24,182 in 56 payments from 13 companies in 2025. Trend: 2023 $526 · 2024 $698 · 2025 $24,182

Speaker / faculty: $18,615Travel & lodging: $3,560Food & beverage: $1,121Consulting: $870Education: $16
CompanyPaymentsAmount
Janssen Biotech, Inc.36$23,858
Novartis Pharmaceuticals Corporation7$102
Immunocore Limited2$32
PFIZER INC.2$29
Sumitomo Pharma America, Inc.1$24
Genmab U.S., Inc.1$22
Ipsen Biopharmaceuticals, Inc1$20
E.R. Squibb & Sons, L.L.C.1$19
GENZYME CORPORATION1$18
Janssen Pharmaceuticals, Inc1$16

Products named: RYBREVANT, DARZALEX, TECVAYLI, KISQALI, SCEMBLIX, CARVYKTI, KIMMTRAK, ELREXFIO.

Industry payments across AR — which companies pay providers there.